Temozolomide in adult patients with advanced soft tissue sarcoma: A phase II study of the EORTC soft tissue and bone sarcoma group

1999-03-01

European Journal of Cancer , Volume 35 - Issue 3 p. 410- 412

Additional Metadata
Keywords	Chemotherapy, Imidazotetrazine, Phase II, Sarcoma, Temozolomide
Persistent URL	doi.org/10.1016/S0959-8049(98)00403-1, hdl.handle.net/1765/70492
Journal	European Journal of Cancer
Organisation	Department of Medical Oncology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Woll, P. J., Judson, I., Lee, S., Rodenhuis, S., Nielsen, O., Buesa, J., Lorigan, P., Leyvraz, S., Hermans, C., van Glabbeke, M.& Verweij, J. (1999). Temozolomide in adult patients with advanced soft tissue sarcoma: A phase II study of the EORTC soft tissue and bone sarcoma group. European Journal of Cancer, 35(3), 410–412.https://doi.org/10.1016/S0959-8049(98)00403-1

Publication